Aging Populations And Digital Health Will Expand Oncology Testing
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
05 Aug 25
Updated
09 Aug 25
AnalystHighTarget's Fair Value
US$12.00
49.3% undervalued intrinsic discount09 Aug
US$6.08
1Y
-63.1%7D
8.2%